News & Updates

Show Multimedia Only

Mass eradication of H. pylori infection eliminates gastric cancer threat

02 Sep 2020

Population-based eradication of Helicobacter pylori infection leads to a marked reduction in gastric cancer incidence with no increase in the likelihood of adverse consequences, a study has found.

Mass eradication of H. pylori infection eliminates gastric cancer threat

02 Sep 2020

Sofosbuvir plus seraprevir therapy effective, safe in HCV genotype 1 infection

02 Sep 2020 by

The combination therapy sofosbuvir-seraprevir appears to be effective and well tolerated in patients with chronic hepatitis C virus (HCV) genotype 1 infection without cirrhosis, results of a phase III trial have shown.

Sofosbuvir plus seraprevir therapy effective, safe in HCV genotype 1 infection

02 Sep 2020

Drug-free remission of HIV seen in ‘elite controllers’

02 Sep 2020 by

Elite HIV controllers—those who can control viral replication without medications—have fewer proviral sequences, a recent study has found. These viral genomes appear to be more concentrated in inaccessible and transcriptionally repressed areas of the genome.

Drug-free remission of HIV seen in ‘elite controllers’

02 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Mass eradication of H. pylori infection eliminates gastric cancer threat

Mass eradication of H. pylori infection eliminates gastric cancer threat

Sofosbuvir plus seraprevir therapy effective, safe in HCV genotype 1 infection

Sofosbuvir plus seraprevir therapy effective, safe in HCV genotype 1 infection

Drug-free remission of HIV seen in ‘elite controllers’

Drug-free remission of HIV seen in ‘elite controllers’